UTAH MEDICAL PRODUCTS INC (UTMD) › Cost of RevenueUTAH MEDICAL PRODUCTS INC (UTMD) — Cost of RevenueAnnual figures by fiscal year, from SEC filings.2016: $15.61M2017: $15.02M2018: $15.69M2019: $17.44M2020: $16.63M2021: $18.14M2022: $20.09M2023: $20.19M2024: $16.76M2025: $16.52M$16.52M2016Cost of Revenue (USD)2025Fiscal YearCost of RevenueChange YoY2025$16.52M-1.4%2024$16.76M-17.0%2023$20.19M+0.5%2022$20.09M+10.7%2021$18.14M+9.1%2020$16.63M-4.6%2019$17.44M+11.1%2018$15.69M+4.5%2017$15.02M-3.8%2016$15.61M—Other metrics: RevenueGross ProfitOperating IncomeNet IncomeEPS (Diluted)Total AssetsTotal LiabilitiesShareholders' EquityCash & EquivalentsOperating Cash FlowCapital ExpendituresShares OutstandingDividends Per Share